GEMMATI, Donato
 Distribuzione geografica
Continente #
NA - Nord America 14.088
EU - Europa 6.211
AS - Asia 3.090
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
SA - Sud America 12
Totale 23.453
Nazione #
US - Stati Uniti d'America 13.947
IT - Italia 1.695
CN - Cina 1.636
DE - Germania 1.289
UA - Ucraina 1.169
PL - Polonia 677
TR - Turchia 615
SG - Singapore 593
GB - Regno Unito 564
FI - Finlandia 272
SE - Svezia 225
CA - Canada 137
ID - Indonesia 87
FR - Francia 67
BE - Belgio 45
SM - San Marino 44
RU - Federazione Russa 40
IN - India 39
CZ - Repubblica Ceca 38
VN - Vietnam 38
HK - Hong Kong 25
IR - Iran 25
IE - Irlanda 15
RO - Romania 14
CH - Svizzera 12
AU - Australia 10
BR - Brasile 10
EG - Egitto 10
NL - Olanda 10
EU - Europa 9
ES - Italia 8
PK - Pakistan 8
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 5
GR - Grecia 5
JP - Giappone 5
NZ - Nuova Zelanda 5
DK - Danimarca 4
MA - Marocco 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
AT - Austria 2
IL - Israele 2
IQ - Iraq 2
KE - Kenya 2
MG - Madagascar 2
MX - Messico 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
HN - Honduras 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
MC - Monaco 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 23.453
Città #
Woodbridge 1.673
Fairfield 1.521
Jacksonville 1.355
Chandler 1.324
Ann Arbor 977
Houston 949
Ashburn 693
Warsaw 674
Wilmington 613
Seattle 599
Cambridge 445
Izmir 418
Singapore 414
Nanjing 388
Beijing 294
Princeton 291
Ferrara 259
Boardman 231
Milan 198
New York 160
San Diego 139
Munich 137
Mcallen 130
Shanghai 129
Montréal 122
Shenyang 117
Dearborn 98
Nanchang 95
Changsha 86
Hebei 86
Jakarta 85
Bremen 81
Santa Clara 73
Jiaxing 70
Los Angeles 65
Tianjin 58
Rome 57
Redwood City 53
Jinan 52
Greven 51
Bottrop 49
Norwalk 49
Falls Church 48
Brussels 43
Bologna 39
Dong Ket 37
Düsseldorf 37
Mountain View 37
Kunming 35
Berlin 34
San Mateo 32
Zhengzhou 31
Orange 30
Brno 28
Des Moines 28
Ningbo 28
Guangzhou 27
Addison 26
London 26
Auburn Hills 25
Helsinki 23
Augusta 22
Hong Kong 22
Napoli 20
Washington 19
Florence 17
Padova 17
Ferrara di Monte Baldo 16
Hangzhou 15
Indiana 13
Leawood 13
Verona 13
Monmouth Junction 12
Meda 11
Ardabil 10
Hefei 10
Changchun 9
Dublin 9
Turin 9
Brescia 8
Catania 8
Chicago 8
Lucknow 8
Philadelphia 8
Domagnano 7
Duncan 7
Genoa 7
Naples 7
Ottawa 7
Pescara 7
San Francisco 7
Taizhou 7
Tappahannock 7
Ansbach 6
Dogana 6
Fuzhou 6
Lanzhou 6
Pavia 6
San Marino 6
Torino 6
Totale 16.374
Nome #
Nanobiomaterials for vascular biology and wound management: a review 1.040
FISIOPATOLOGIA DELL'EMOSTASI E DELLA COAGULAZIONE 432
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 423
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 263
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 216
High throughput array technologies: Expanding applications from clinics to applied research 185
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 183
Realizzazione di un DNA-Array di varianti genetiche nelle lesioni croniche di origine vascolare 175
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 168
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 162
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes: new insights from a case-control study 161
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 160
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 158
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 153
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 152
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 144
Fisiopatologia della Coagulazione. 143
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 139
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 139
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 138
Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers 135
FOLATE GENE VARIANTS AFFECT METHOTREXATE-RELATED TOXICITY IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS 133
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 132
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 128
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 128
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 124
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival 124
Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage 123
MTHFR 677C>T Polymorphism and Risk of Coronary Heart Disease. 122
Prognostic role of Factor XIII gene variants in nonhealing venous leg ulcers 122
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review 122
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 122
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 122
Genetic predictors of response to photodynamic therapy 120
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis 120
Meta-analysis of multiple sclerosis microarray data reveals dysregulation in RNA splicing regulatory genes 119
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 119
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 118
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 118
null 118
Polymorphisms in the genes coding for iron binding and transporting proteins are Associated with Disability, Severity, and Early Progression in Multiple Sclerosis. 117
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 116
Influence of gene polymorphisms in ulcer healing process after superficial venous surgery 115
Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants 115
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 115
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 114
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 114
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 113
Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields 112
DNA-Array of gene variants in venous leg ulcers: detection of prognostic indicators. 112
A photometric assay for factor-XIII in chronic hepatopathies. 112
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 111
Partial gene deletion in a family with factor X deficiency 111
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 110
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 109
Detection and characterization of polymorphic markers in the factor-VII gene. 109
Investigation of in vitro cytotoxicity of the redox state of ionic iron in neuroblastoma cells. 108
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 108
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 107
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 107
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 107
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 105
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 105
TIME- AND DOSE-DEPENDENT EFFECTS OF CHRONIC WOUND FLUID ON HUMAN ADULT DERMAL FIBROBLASTS 105
Folate: metabolism, biochemistry and role in disease processes. 104
Nanoengineering Approaches to Design Advanced Dental Materials for Clinical Applications. 104
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 104
Functional properties of factor V and factor Va encoded by the R2-gene 103
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 103
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 102
Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration 101
null 100
Karyotype-Phenotype Correlation in Partial Trisomies of the Short Arm of Chromosome 6: A Family Case Report and Review of the Literature. 100
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 100
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 99
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer 99
Clinical implications of gene polymorphisms in venous leg ulcer: A model in tissue injury and reparative process 98
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation. 98
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 98
null 97
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 97
null 97
null 97
null 96
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 95
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 95
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 95
Quantitive evaluation of dentin sialoprotein (DSP) using microbeads - A potential early marker of root resorption 95
Influence of Genetic Polymorphisms in Ulcer Healing Process after Superficial Venous Surgery 93
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 93
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 92
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 91
null 91
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 90
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 90
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 89
null 88
null 88
null 88
null 86
Totale 13.316
Categoria #
all - tutte 97.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.945
Totale 101.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.888 0 0 149 635 341 602 415 507 321 555 248 115
2020/20213.771 362 343 201 365 226 424 181 420 105 494 476 174
2021/20223.009 210 380 272 98 247 124 118 116 101 253 301 789
2022/20233.069 328 212 78 377 496 507 167 279 317 32 174 102
2023/20241.611 148 190 69 46 162 247 49 110 34 53 75 428
2024/2025886 204 157 525 0 0 0 0 0 0 0 0 0
Totale 23.840